chemotherapy

September 3, 2015

Hach shows age not always a barrier to cancer therapy

Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years.

By VUMC News and Communications
brain
August 20, 2015

Study seeks to ease ‘chemobrain’ for cancer patients

Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment.

By Nancy Humphrey
August 11, 2015

Drug combos enhance ovarian cancer cell death

Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.

By Leigh MacMillan
June 25, 2015

Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

By Jessica Pasley
May 28, 2015

Dietitian and friends donate chemo care bags to VICC patients

A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients.

By VUMC News and Communications
October 28, 2014

Improving breast cancer chemo by testing tumors in a dish

A team of biomedical engineers has developed a new “tumor-in-a-dish” technology that promises to improve the effectiveness of chemotherapy.

By VUMC News and Communications
April 30, 2014

Potential mechanism for myeloma drug’s variable toxicity

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
By Leigh MacMillan
August 22, 2013

Overcoming resistance in ovarian cancer

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.
By Leigh MacMillan
June 24, 2013

Predicting cancer’s response to therapy

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.
By Leigh MacMillan
December 24, 2012

A drug combo for ovarian cancer

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.
By Leigh MacMillan
June 11, 2012

Vanderbilt identifies genes linked to breast cancer chemo resistance

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
By VUMC News and Communications
May 22, 2012

Vanderbilt lands significant patient-centered research grant

Patients and their families will have a more active role and voice in research designed to improve the quality and safety of patient care, thanks to a federal grant received by Vanderbilt University Medical Center researchers.
By Jill Clendening
1 2 3